RBC Capital Markets Advises Tolmar on Acquisition of JATENZO from Clarus Therapeutics
Tolmar Pharmaceuticals, a fully integrated pharmaceutical company, through its affiliate, Tolmar, acquired of all rights to JATENZO from Clarus Therapeutics Holdings and its wholly-owned subsidiary Clarus Therapeutics.